01487nas a2200205 4500000000100000008004100001260002500042653001000067653002100077653002500098653002200123653002400145100001200169700001500181700001300196245007000209300001200279520096500291022002501256 2025 d bA and V Publications10aTulsi10aImmunomodulation10aAntibacterial action10aleprosy treatment10aMedicine, Ayurvedic1 aPatil V1 aSonawane P1 aKakade R00aOcimum sanctum as a Potential Supplementary Treatment for Leprosy a235-2413 a
Millions are afflicted with leprosy, a persistent bacterial infection that is most common in tropical areas. The problems with conventional treatments include side effects and antibiotic resistance. This research investigates the potential for treating leprosy with Ocimum sanctum L., or Tulsi plant that is highly valued in Ayurvedic and Siddha therapy. Tulasi exhibits antibacterial, anti-inflammatory, and antioxidant pharmacological characteristics that are effective against Mycobacterium leprae. The bioactive substances in the plant, like ursolic acid and eugenol, have immunomodulatory properties that strengthen the body's defenses against infection. The current literature on Tulasi's therapeutic uses is compiled in this review, which emphasizes the drug's potential as a leprosy adjuvant or substitute treatment. The plant's safety record, accessibility, and possibility for combined treatment with traditional antibiotics are all covered.
a0975-4385, 0975-2331